Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat

International Journal of Obesity volume 35, pages 658–665 (2011)Cite this article

Subjects

Abstract

Objective:

To investigate the anti-obesity effect of the adipokine zinc-α2-glycoprotein (ZAG) in rats and the mechanism of this effect.

Subjects:

Mature male Wistar rats (540±83 g) were administered human recombinant ZAG (50 μg per 100 g body weight given intravenously daily) for 10 days, while control animals received an equal volume of phosphate-buffered saline (PBS).

Results:

Animals treated with ZAG showed a progressive decrease in body weight, without a decrease in food and water intake, but with a 0.4 °C rise in body temperature. Body composition analysis showed loss of adipose tissue, but an increase in lean body mass. The loss of fat was due to an increase in lipolysis as shown by a 50% elevation of plasma glycerol, accompanied by increased utilization of non-esterified fatty acids, as evidenced by the 55% decrease in plasma levels. Plasma levels of glucose and triglycerides were also reduced by 36–37% and there was increased expression of the glucose transporter 4 in both skeletal muscle and adipose tissue. Expression of the lipolytic enzymes adipose triglyceride lipase and hormone-sensitive lipase in the white adipose tissue (WAT) were increased twofold after ZAG administration. There was almost a twofold increased expression of uncoupling proteins 1 and 3 in brown adipose tissue and WAT, which would contribute to increased substrate utilization. Administration of ZAG increased ZAG expression twofold in the gastrocnemius muscle, BAT and WAT, which was probably necessary for its biological effect.

Conclusion:

These results show that ZAG produces increased lipid mobilization and utilization in the rat.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  1. Rössner S . Obesity: the disease of the twenty-first century. Int J Obes 2002; 26 (Suppl 4): 52–54.

    Google Scholar 

  2. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ . Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 1998; 58: 2359–2365.

    CAS  Google Scholar 

  3. Russell ST, Zimmerman TP, Domin BA, Tisdale MJ . Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein. Biochim Biophys Acta 2004; 1636: 59–68.

    Article  CAS  Google Scholar 

  4. Araki T, Gejyo F, Takagaki K, Haupt H, Schwick G, Burgi W et al. Complete amino acid sequence of human plasma zinc-α2-glycoprotein and its homology to histo-compatability antigens. Proc Natl Acad Sci USA 1988; 85: 679–683.

    Article  CAS  Google Scholar 

  5. Todorov PT, McDevitt TM, Meyer DJ, Ueyama H, Ohkubo I, Tisdale MJ . Purification and characterization of a tumor lipid-mobilizing factor. Cancer Res 1998; 58: 2353–2358.

    CAS  Google Scholar 

  6. Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S et al. Zinc α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 2004; 101: 2500–2505.

    Article  CAS  Google Scholar 

  7. Russell ST, Tisdale MJ . The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexia. Br J Cancer 2005; 92: 876–881.

    Article  CAS  Google Scholar 

  8. Dahlman I, Kaaman M, Olsson T, Tan GD, Bickerton AST, Wahlen K et al. A unique role of moncyte chemoattractant protein 1 among chemokines in adipose tissue of obese subjects. J Endocrinol Metab 2005; 90: 5834–5840.

    Article  CAS  Google Scholar 

  9. Mracek T, Ding Q, Tzanavari T, Kos K, Pinkney J, Wilding J et al. The adipokine zinc-α2-glycoprotein is downregulated with fat mass expansion in obesity. Clin Endocrinol 2010; 72: 334–341.

    Article  CAS  Google Scholar 

  10. Gohda T, Makita Y, Shike T, Tanimoto M, Funabiki K, Horikoshi S et al. Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a type 2 diabetes model. Is Zn-α2-glycoprotein-1 a candidate gene for obesity? Diabetes 2003; 52: 2175–2181.

    Article  CAS  Google Scholar 

  11. Rolli V, Radosavljevic M, Astier V, Macquin C, Castan-Laurell I, Visentin V et al. Lipolysis is altered in MHC class I zinc-α2-glycoprotein deficient mice. FEBS Lett 2007; 581: 394–400.

    Article  CAS  Google Scholar 

  12. Ueyama H, Naitoh H, Ohkubo I . Structure and expression of rat and mouse mRNAs for Zn-α2-glycoprotein. J Biochem 1994; 116: 677–681.

    Article  CAS  Google Scholar 

  13. Beck SA, Tisdale MJ . Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res 1987; 47: 5919–5923.

    CAS  PubMed  Google Scholar 

  14. Wieland O . Glycerol UV method. In: Bergmeyer HU (ed.). Methods of Enzymatic Analysis. Academic Press: London, 1974. pp 1404–1409.

    Google Scholar 

  15. Russell ST, Tisdale MJ . Antidiabetic properties of zinc-α2-glycoprotein (ZAG) in ob/ob mice. Endocrinology 2010; 151: 948–957.

    Article  CAS  Google Scholar 

  16. Lundholm K, Edström S, Karlberg I, Ekman L, Schersten T . Relationship of food intake, body composition and tumor growth to host metabolism in nongrowing mice with sarcoma. Cancer Res 1980; 40: 2515–2522.

    Google Scholar 

  17. Nisoli E, Tonello C, Landi M, Carruba MO . Functional studies of the first selective β3-adrenergic receptor antagonist SR59230A in rat brown adipocytes. Mol Pharmacol 1996; 44: 7–14.

    Google Scholar 

  18. Eley HL, Tisdale MJ . Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation. J Biol Chem 2007; 282: 7087–7097.

    Article  CAS  Google Scholar 

  19. Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F . Zinc α2-glcyoprotein: a multidisciplinary protein. Mol Cancer Res 2008; 6: 892–906.

    Article  CAS  Google Scholar 

  20. Haemmerle G, Lass A, Zimmerman R, Gorkiewicz G, Meyer C, Rozman J et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006; 312: 734–737.

    Article  CAS  Google Scholar 

  21. Osuga J, Ishibashi S, Oka T, Yagyu H, Tozawa R, Fujimoto A et al. Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity. Proc Natl Acad Sci USA 2000; 97: 787–792.

    Article  CAS  Google Scholar 

  22. Jocken JWE, Langin D, Smit E, Saris WHM, Valle C, Hul GB et al. Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state. J Clin Endocinol Metab 2007; 92: 2292–2299.

    Article  CAS  Google Scholar 

  23. Beck SA, Tisdale MJ . Effect of cancer cachexia on triacylglycerol/fatty acid substrate cycling in white adipose tissue. Lipids 2004; 39: 1187–1189.

    Article  CAS  Google Scholar 

  24. Susulic VS, Frederich RC, Lawitts J, Tozze L, Kahn BB, Harper ME et al. Targeted disruption of the β3-adrenergic receptor gene. J Biol Chem 1995; 270: 29483–29492.

    Article  CAS  Google Scholar 

  25. Marette A, Bukoqiecki LJ . Stimulation of glucose transport by insulin and norepinephrine in isolated rat brown adipocytes. Am J Physiol Cell Physiol 1989; 257: C714–C721.

    Article  CAS  Google Scholar 

  26. Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB et al. Protein kinase B kinases that mediate phosphatidyl-inositol 3, 4, 5-triphosphate-dependent activation of protein kinase B. Science 1998; 279: 710–714.

    Article  CAS  Google Scholar 

  27. Russell ST, Tisdale MJ . Effect of a tumour-derived lipid-mobilising factor on glucose and lipid metabolism in vivo. Br J Cancer 2002; 87: 580–584.

    Article  CAS  Google Scholar 

  28. Russell ST, Hirai K, Tisdale MJ . Role of β3-adrenergic receptors in the action of a tumour lipid mobilising factor. Br J Cancer 2002; 86: 424–428.

    Article  CAS  Google Scholar 

  29. Sanders PM, Tisdale MJ . Effect of zinc-α2-glycoprotein (ZAG) on expression of uncoupling proteins in skeletal muscle and adipose tissue. Cancer Lett 2004; 212: 71–81.

    Article  CAS  Google Scholar 

  30. Ghorbani M, Himms-Hagen J . Appearance of brown adipocytes in white adipose tissue during CL316, 243-induced reversal of obesity and diabetes in Zucker fa/fa rats. Int J Obes 1997; 21: 465–475.

    Article  CAS  Google Scholar 

  31. Inokuma K, Okamatsu-Ogura Y, Omachi A, Matsushita Y, Kimura K, Yamashita H et al. Indispensable role of mitochondrial UCP1 for antiobesity effect of β3-adrenrgic stimulation. Am J Physiol Endocrinol Metab 2006; 290: E1014–E1021.

    Article  CAS  Google Scholar 

  32. Vallerand AL, Perusse F, Bukowiecki LJ . Cold exposure reverses inhibitory effects of fasting on peripheral glucose uptake in rats. Am J Physiol Regul Integr Comp Physiol 1989; 259: R1043–R1049.

    Article  Google Scholar 

  33. Barbe P, Millet L, Galitzky J, Lafontan M, Berlan M . In situ assessment of the role of the β1-,β2-, and β3-adrenoreceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br J Pharmacol 1996; 117: 907–913.

    Article  CAS  Google Scholar 

  34. Weyer C, Tataranni PA, Snitker S, Danforth Jr E, Ravussin E . Increase in insulin action and fat oxidation after treatment with CL316, 243, a highly selective β3-adrenoreceptor agonist in humans. Diabetes 1998; 47: 1555–1561.

    Article  CAS  Google Scholar 

  35. Revelli J-P, Muzzin P, Giacobino J-P . Modulation in vivo of β-adrenergic receptor subtypes in rat brown adipose tissue by the thermogenic agonist Ro16-8714. Biochem J 1992; 286: 743–7462.

    Article  CAS  Google Scholar 

  36. Yeung DCY, Lam KSL, Wang Y, Tso AWK, Xu X . Serum zinc-alpha 2-glycoprotein correlates with adiposity, triglycerides and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab 2009; 94: 2531–2536.

    Article  CAS  Google Scholar 

  37. Russell ST, Tisdale MJ . The role of glucocorticoids in the induction of zinc-α2-glycoprotein expression in adipose tissue in cancer cachexia. Br J Cancer 2005; 92: 876–881.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Mr Brian Burford for help with the animal experiments. This work was supported by a research grant from Halsa Pharmaceuticals, TX, USA.

Author information

Authors and Affiliations

  1. Nutritional Biomedicine, School of Life and Health Sciences, Aston University, Birmingham, UK

    S T Russell & M J Tisdale

Authors
  1. S T Russell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M J Tisdale
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M J Tisdale.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russell, S., Tisdale, M. Studies on the anti-obesity activity of zinc-α2-glycoprotein in the rat. Int J Obes 35, 658–665 (2011). https://doi.org/10.1038/ijo.2010.193

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2010.193

Keywords

This article is cited by

Search

Advanced search

Quick links